Kenneth Bate Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 months ago
Kenneth Bate has an estimated net worth of at least $12.9 million*, as of Oct. 29, 2025. They own shares of MDGL stock. They have sold 59,064 shares of MDGL stock since 2021, for an estimated $11.9 million.
Kenneth Bate $MDGL SEC Form 4 Insider Trading
Kenneth Bate has filed a total of 34 insider trades in $MDGL since 2021. Their most recent trade was a sale of 827 shares, made on Nov 05, 2025. Their largest trade was a sale of 7,411 shares, made on Apr 01, 2024. We estimate that they now own shares of $MDGL, worth an estimated $1.1 million.
Insider Trading at $MDGL
There have been a total of 650 insider trades reported at $MDGL since 2021, with 590,368 shares purchased and 876,162 shares sold. The most active insider traders in $MDGL stock have been Brian Joseph Lynch, Mardi Dier, and Rebecca Taub. The most recent trade was a sale of 40 shares reported by Mardi Dier (EVP and CFO), made on Mar 06, 2026.
History of Insider Stock Trades by Kenneth Bate
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MDGL
|
Sale | 827 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 2,775 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 696 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 933 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 30 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 1,763 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 3,259 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 1,284 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 2,069 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 1,931 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 1,008 | Nov 05, 2025 | Nov. 7, 2025, 5:20 p.m. |
MDGL
|
Sale | 2,317 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
MDGL
|
Sale | 2,567 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
MDGL
|
Sale | 600 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
MDGL
|
Sale | 1,104 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
MDGL
|
Sale | 896 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
MDGL
|
Sale | 2,516 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
MDGL
|
Sale | 7 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 6,698 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 7,411 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 2,790 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 2,104 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 200 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 841 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 143 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 116 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 700 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 274 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 1,217 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 7,048 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 2,080 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 567 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 100 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
MDGL
|
Sale | 193 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
$MDGL Executives and Stock Owners with Insider Trades
-
Brian Joseph Lynch, SVP and General Counsel
-
Mardi Dier, EVP and CFO
-
Rebecca Taub, Pres., R&D, and CMO
-
Carole Huntsman, Chief Commercial Officer
-
Robert E. Waltermire, Senior VP, Chief Pharma Dev.
-
Remy Sukhija, Chief Commercial Officer
-
Shannon T Kelley, General Counsel
-
William John Sibold, President and CEO
-
Mardi Dier, SVP and CFO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.